Both in Pharmaceuticals
Prothena vs CorMedix
Over the past year PRTA returned −18.2% and CRMD returned −50.4%; their daily moves had a correlation of 0.22.
PRTA −18.2% CRMD −50.4%Growth of $1, one year, split-adjusted
| Metric | PRTA | CRMD |
|---|---|---|
| Price | $8.39 | $5.66 |
| Market cap | $430.7M | $441.2M |
| Today | +2.19% | +1.80% |
| 1 month | +4.6% | −22.3% |
| 6 months | −25.0% | −29.7% |
| Year to date | −12.1% | −51.3% |
| 1 year | −20.4% | −51.0% |
| Revenue growth (YoY) | −77.1% | +156.5% |
| Gross margin | 100.0% | 75.7% |
| Net margin | −1839.9% | 25.5% |
| P/E (TTM) | — | 2.4× |
| Price / sales | 7.9× | 1.0× |
| Net cash | $288.2M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 45.9% | 77.3% |
| Short % of float | 18.9% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).